Cargando…

Plasmodium vivax in Children: Hidden Burden and Conspicuous Challenges, a Narrative Review

There has been progress towards decreasing malaria prevalence globally; however, Plasmodium vivax has been less responsive to elimination efforts compared with Plasmodium falciparum. P. vivax malaria remains a serious public health concern in regions where it is the dominant species (South and South...

Descripción completa

Detalles Bibliográficos
Autores principales:	Drysdale, Myriam, Tan, Lionel, Martin, Ana, Fuhrer, Isabelle Borghini, Duparc, Stephan, Sharma, Hema
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9868225/ https://www.ncbi.nlm.nih.gov/pubmed/36378465 http://dx.doi.org/10.1007/s40121-022-00713-w

Ejemplares similares

Efficacy and Safety of Pyronaridine–Artesunate for the Treatment of Uncomplicated Plasmodium falciparum and Plasmodium vivax Malaria in Myanmar
por: Han, Kay Thwe, et al.
Publicado: (2020)

Pyronaridine-Artesunate versus Chloroquine in Patients with Acute Plasmodium vivax Malaria: A Randomized, Double-Blind, Non-Inferiority Trial
por: Poravuth, Yi, et al.
Publicado: (2011)

Diagnosis and Treatment of Plasmodium vivax Malaria
por: Baird, J. Kevin, et al.
Publicado: (2016)

Neurological and psychiatric safety of tafenoquine in Plasmodium vivax relapse prevention: a review
por: Duparc, Stephan, et al.
Publicado: (2020)

Active Pharmacovigilance for Primaquine Radical Cure of Plasmodium vivax Malaria in Odisha, India
por: Anvikar, Anupkumar R., et al.
Publicado: (2022)

The global burden of Plasmodium vivax malaria is obscure and insidious
por: Battle, Katherine E., et al.
Publicado: (2021)

Estimation of the Antirelapse Efficacy of Tafenoquine, Using Plasmodium vivax Genotyping
por: Beck, Hans-Peter, et al.
Publicado: (2016)

Review of the clinical pharmacokinetics of artesunate and its active metabolite dihydroartemisinin following intravenous, intramuscular, oral or rectal administration
por: Morris, Carrie A, et al.
Publicado: (2011)

Plasmodium vivax Landscape in Brazil: Scenario and Challenges
por: Siqueira, Andre M., et al.
Publicado: (2016)

Defining the Erythrocyte Binding Domains of Plasmodium vivax Tryptophan Rich Antigen 33.5
por: Bora, Hema, et al.
Publicado: (2013)

The burden of Plasmodium vivax relapses in an Amerindian village in French Guiana
por: Nacher, Mathieu, et al.
Publicado: (2013)

Potential hidden Plasmodium vivax malaria reservoirs from low parasitemia Duffy-negative Ethiopians: Molecular evidence
por: Abebe, Abnet, et al.
Publicado: (2023)

Conspicuous Chameleons
por: O'Day, Kira E
Publicado: (2008)

Molecular epidemiology of Plasmodium vivax anti-folate resistance in India
por: Prajapati, Surendra K, et al.
Publicado: (2011)

Effectiveness of pyronaridine-artesunate against Plasmodium malariae, Plasmodium ovale spp, and mixed-Plasmodium infections: a post-hoc analysis of the CANTAM-Pyramax trial
por: Groger, Mirjam, et al.
Publicado: (2022)

Plasmodium vivax Sporozoite Challenge in Malaria-Naïve and Semi-Immune Colombian Volunteers
por: Arévalo-Herrera, Myriam, et al.
Publicado: (2014)

Challenges for achieving safe and effective radical cure of Plasmodium vivax: a round table discussion of the APMEN Vivax Working Group
por: Thriemer, Kamala, et al.
Publicado: (2017)

Burden and impact of Plasmodium vivax in pregnancy: A multi-centre prospective observational study
por: Bardají, Azucena, et al.
Publicado: (2017)

Allelic dimorphism of Plasmodium vivax gam-1 in the Indian subcontinent
por: Prajapati, Surendra K, et al.
Publicado: (2006)

Antibody Profiling in Naïve and Semi-immune Individuals Experimentally Challenged with Plasmodium vivax Sporozoites
por: Arévalo-Herrera, Myriam, et al.
Publicado: (2016)

Pharmacogenetic assessment of tafenoquine efficacy in patients with Plasmodium vivax malaria
por: St Jean, Pamela L., et al.
Publicado: (2020)

Plasmodium vivax msp-3α polymorphisms: analysis in the Indian subcontinent
por: Verma, Anju, et al.
Publicado: (2016)

Optimal dose finding for novel antimalarial combination therapy*
por: Duparc, S, et al.
Publicado: (2012)

Multiplicity of Infection and Disease Severity in Plasmodium vivax
por: Pacheco, M. Andreína, et al.
Publicado: (2016)

Plasmodium vivax Malaria
por: Kochar, Dhanpat K., et al.
Publicado: (2005)

Attacking Plasmodium vivax
por: Baird, J. Kevin
Publicado: (2016)

Predator feeding choice on conspicuous and non-conspicuous carabid beetles: first results
por: Bonacci, Teresa, et al.
Publicado: (2011)

Overcoming challenges to discover drugs for liver stages of Plasmodium vivax
por: Kyle, Dennis E
Publicado: (2014)

Development of novel vaccine candidates and challenge models for Plasmodium vivax
por: Alves, Eduardo, et al.
Publicado: (2014)

Taking on Plasmodium vivax malaria: A timely and important challenge
por: von Seidlein, Lorenz, et al.
Publicado: (2021)

Tafenoquine co-administered with dihydroartemisinin–piperaquine for the radical cure of Plasmodium vivax malaria (INSPECTOR): a randomised, placebo-controlled, efficacy and safety study
por: Sutanto, Inge, et al.
Publicado: (2023)

Safety and efficacy of pyronaridine-artesunate in uncomplicated acute malaria: an integrated analysis of individual patient data from six randomized clinical trials
por: Duparc, Stephan, et al.
Publicado: (2013)

Plasmodium vivax gametocyte infectivity in sub-microscopic infections
por: Vallejo, Andrés F., et al.
Publicado: (2016)

Transcription Profiling of Malaria-Naïve and Semi-immune Colombian Volunteers in a Plasmodium vivax Sporozoite Challenge
por: Rojas-Peña, Monica L., et al.
Publicado: (2015)

Antigenic repertoire of Plasmodium vivax transmission-blocking vaccine candidates from the Indian subcontinent
por: Prajapati, Surendra K, et al.
Publicado: (2011)

Antimalarial activity of artefenomel (OZ439), a novel synthetic antimalarial endoperoxide, in patients with Plasmodium falciparum and Plasmodium vivax malaria: an open-label phase 2 trial
por: Phyo, Aung Pyae, et al.
Publicado: (2016)

Haematological response in experimental human Plasmodium falciparum and Plasmodium vivax malaria
por: Woolley, Stephen D., et al.
Publicado: (2021)

Tafenoquine for the radical cure versus prophylaxis of Plasmodium vivax malaria: the importance of using the appropriate data set
por: Sharma, Raman, et al.
Publicado: (2023)

Monitoring Plasmodium vivax resistance to antimalarials: Persisting challenges and future directions
por: Ferreira, Marcelo U., et al.
Publicado: (2020)

Plasmodium vivax Genetic Diversity in Panama: Challenges for Malaria Elimination in Mesoamerica
por: Santamaría, Ana María, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vtd3ogmh8d0a4umrchuamtar8m